For Med- and HealthTech Startups
You've built an innovative MedTech or HealthTech solution addressing a global unmet need. You raised pre-seed capital and secured regulatory approval. But commercialization requires a different set of capabilities.
What you get with the Vectrix method:
- 5-10x Seed and A-round valuation
- Hospital pilots which convert to high revenue agreements
- Tier 1 global OEM commercial agreements generating significant revenues starting year 1
- Lead pipelines converting into revenue-generating partnering agreements
See our case studies | Book a free 30-minute call
Healthcare Commercialization Services
Market Entry Strategy
Go-to-market planning, regulatory pathway mapping, and market access strategy development.
Strategic Partnerships
OEM partnerships, distribution agreements, and strategic alliance development.
Fundraising Support
Investment readiness, investor connections, and fundraising strategy execution.
Exit Strategy
Acquisition preparation, strategic buyer identification, and exit execution.
For Investors
We help investors de-risk MedTech and Digital Health by ensuring early commercial agreements, revenue visibility, and a clear go-to-market plan.
- Pre-screened companies with regulatory or clinical validation
- Evidence of traction: early revenue, signed LOIs, or advanced buyer discussions
- Go-to-market plans backed by real-world procurement insights
- Clear use-of-funds plans tied to commercial traction milestones
- Vetted founding teams, with our operational and strategic commercial support behind them
Client Success Stories
Cerebriu — AI Radiology (MedTech/AI)
Result: Series A funding & Global OEM partnership
Supported Cerebriu's commercial expansion (pre-regulatory approval), contributing to strategic positioning, partnership development, and key commercial hires. This supported the company's broader success, including a USD 19M Series A—one of the largest in Danish digital health.
Challenge: Cerebriu had developed advanced radiology AI technology and was entering a phase of international growth. To scale effectively, the company sought external commercial expertise to support strategic partnerships, global sales enablement, and commercial team expansion.
Solution: Vectrix provided targeted commercial advisory support over a multi-year period, including advising on go-to-market strategies across direct sales, distribution, and OEM channels; mapping potential distribution and partnership opportunities; supporting selected commercial negotiations; and facilitating introductions and contributing to hiring of key commercial roles in Europe and the US.
"Thomas' (VECTRIX.Health) commercial focus and partnership mindset make a real difference." — Robert Lauritzen, CEO, Cerebriu
Eyemind (GazeDriver) — Assistive Technology (Hardware)
Result: Successful exit in 12 months
Commercialized early-stage startup and facilitated successful acquisition by global OEM Meyra Group within 12 months. Improved pricing structure by 2-3x original expectations.
"Thomas created essential stability during our international market journey." — Kim Søborg, CEO, Eyemind
OpenTeleHealth (Doccla) — Digital Telemedicine (Software)
Result: Strategic partnerships & Acquisition
Negotiated strategic partnerships with Siemens Healthineers and Accenture, leading to successful acquisition by UK-based Doccla.
"Thomas has a unique international B2B sales profile. He quickly focused our resources on the right partners." — Henrik Ibsen, CEO, OpenTeleHealth
Candor — Radiation Therapy Equipment (Medical Device)
Result: Global distribution & Market expansion
Improved international distributor network performance in DACH region, set up pre-FDA US distribution strategy, and mapped 10+ distributor agreements across EU, UK, and US.
"Thomas helped us build better distributor networks internationally, significantly accelerating our sales." — Henrik Mortensen, CEO, Candor
Hedia — Diabetes Management App (Digital Health)
Result: Market expansion & Clinical validation
Provided strategic market analysis and opened critical access to German healthcare insurers (Krankenkassen) for diabetes management app.
"His market analysis and strategic insights opened critical doors in the German healthcare market." — Benjamin Suhr, CCO, Hedia
Qualcomm Life — Telehealth Connectivity (Digital Health)
Result: #1 Global Sales Region
Built EU division from scratch to #1 global sales region with 500+ developer ecosystem including Philips, GE Healthcare, and Roche.
"Thomas rapidly designed the business model enabling swift revenue generation, always exceeding targets." — Laurent Vandebrouck, Managing Director EU, Qualcomm Life
What Our Clients Say
"Thomas created essential stability during our international market journey. Strong recommendation."
"Thomas' commercial focus and partnership mindset make a real difference. Excited about what we've achieved already."
"Thomas rapidly designed the business model enabling swift revenue generation, always exceeding targets."
"Thomas has a unique international B2B sales profile. He quickly focused our resources on the right partners, fine-tuned our marketing, and realized significant revenue growth."
"Thomas helped us build better distributor networks internationally, significantly accelerating our sales."
Meet the Team
Thomas Juhl Olesen
Founder & CEO
20+ years in global MedTech commercialization. Built Qualcomm's digital health business in Europe, closed deals with Siemens Healthineers, GE, and Roche, and helped startups raise capital through real commercial traction.
Peter GJ Vanovertveld
Principal Consultant
25+ years in global healthcare and MedTech commercialization. Held senior roles at Smart Reporting, Vifor, Baxalta, Baxter and GPC International, building and scaling commercial teams across Europe, North America, and Asia-Pacific.
Frequently Asked Questions
What does a healthcare commercialization consultant do?
A healthcare commercialization consultant helps MedTech and HealthTech startups convert regulatory approval into revenue. This includes go-to-market strategy, OEM and distributor partnership development, pricing optimization, and fundraising support. At VECTRIX.Health, we act as hands-on interim Chief Commercial Officers for Seed to Series A stage companies.
How long does it take to build a go-to-market strategy for a medical device?
With the Vectrix method, your top leads are qualified and prioritized in the first month, with tailored value propositions and outreach launched to secure discovery meetings. From there, we drive toward a high-value Letter of Intent with OEMs and/or distributors that includes tangible mutual commercial deliverables.
How do I find OEM or distributor partners for my medical device?
We leverage our multi-market network and curated investor relationships to identify and qualify potential OEM and distribution partners. Our approach includes international market mapping, strategic partner identification, commercial negotiation support, and structuring agreements with minimum revenue guarantees.
Can grant funding offset the cost of commercialization consulting?
Yes. Most of our clients secure non-dilutive grants that can offset up to 50% of our fees. We have identified relevant European and national programs, and we draft, submit, and manage each application so you can stay focused on product and patients.
What results has VECTRIX.Health achieved for clients?
Our results include contributing to one of Denmark's largest Series A rounds (USD 19M for Cerebriu), facilitating a successful acquisition within 12 months (Eyemind/Meyra Group), growing a zero-revenue pipeline to over €1M ARR in 6 months, and securing global OEM agreements with minimum revenue guarantees for multiple clients.
What markets does VECTRIX.Health cover?
Headquartered in Zurich, Switzerland — Europe's #1 MedTech hub — we cover European and North American markets. Through our founders' Scandinavian roots we also bring in-depth knowledge of the Nordic ecosystem. We have mapped and negotiated distributor agreements across the EU, UK, US, and DACH region.